NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Yes so true. Targeting one or even several cancer antigens is never going to cut it. We have seen other treatments that do this, not with a toxic payload, but just by activating our immune system to target these select antigens. What typically happens is there will be some initial improvement but then the cancer returns with vengeance as it mutates into a form without those select antigens. Now if they had some type of process like DCVAX that targets the full spectrum of cancer antigens that they could tune for each patient then they might have something . . . but not seeing how they could do that. GOOD LUCK & Merry Christmas Flip!!! Hopefully we will be getting new on approval soon soon.